| ||||||||||||||
| |||||||||||||||
| EDUCATION | |
| 1982 | M.D. Medicine, University of Arkansas |
| 1978 | B.A. Chemistry, Yale University |
| POSTDOCTORAL TRAINING | |
| 1986-87 | Fellow, Breast/Gynecologic Pathology - Georgetown University |
| 1985-86 | Chief Resident, Pathology, AP/CP – George Washington University |
| 1982-86 | Resident, Pathology, AP/CP – George Washington University |
DESCRIPTION OF RESEARCH
The focus of my research is in breast and gynecologic pathology. I participate
in many multidisciplinary research efforts, in conjunction with my colleagues in
clinical and basic science disciplines. I direct the San Antonio Cancer
Institute’s Pathology Core, which supports investigators in all the research
programs in the Cancer Institute. The Pathology Core also houses a tissue bank
with thousands of tissue samples available to investigators needing tumors or
control tissues for their investigations. Specialized techniques available in
my laboratory include construction of tissue arrays and laser tissue
microdissection.
SELECTED PUBLICATIONS
1. Yeh I: Atlas of Microscopic Artifacts and Foreign Material.
Baltimore, Williams & Wilkins Publishers, 1997.
2. Lin WM, Forgacs E, Warshal DP, Yeh IT, Martin J, Ashfaq R,
Muller C: Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene
in synchronous endometrial and ovarian carcinomas. Clin Cancer Res 4:2577-83,
1998.
3. Fleisher AC, Wheeler JE, Yeh I, Kravitz B, Jensen C, MacDonald
B: Sonographic assessment of the endometrium in osteopenic postmenopausal women
treated with idoxifene. J Ultrasound Med. 18:503-12, 1999.
4. Yeh I, Zaloudek C, Kurman R: Functioning ovarian tumors and
tumor-like conditions of the ovary. In Becker KL (ed.): Principles and Practice
of Endocrinology and Metabolism, 3rd Ed. Philadelphia, J.B. Lippincott Company,
2001.
5. Zhang YJ, Davis T, Wang WP, Deng JH, Baillargeon J, Yeh I,
Jensen H, Gao SJ: Distinct distribution of rare US KSHV genotypes in South
Texas: Implication for KSHV epidemiology. J Infect Dis 183(1):125-129, 2001.
6. Pikar JH, Yeh I, Wheeler JE, Cunnane MF, Speroff L: Endometrial
effects of lower doses of conjugated equine estrogens and medroxyprogesterone
acetate. Fertility and Sterility 75(1), 2001.
7. Chan J, Robinson ES, Yeh I, Samollow P, McCarrey JR: Absence of
ras gene mutations in UV-induced malignant melanomas correlates with a dermal
origin of melanocytes in Monodelphis domestica Cancer Letters 184:73-80. 2002.
8. Newman SL, Griffith AY, Herbst AB, Yeh I, and Kukora JS. An
unusual presentation of metastatic papillary thyroid cancer: Radioi odine
uptake in lymph node metastases in a patient with Graves’ disease. Endocrine
Practice 8:304-6, 2002.
9. Miller AR, Thomason VE, Yeh I, Alrahwan A, Sharkey FE, Stauffer J,
Otto PM, McKay C, Kahlenberg MS, Blumhardt R,. Phillips WT, Cruz A.
Analysis of Sentinel Lymph Node Mapping with Immediate Pathologic Review in
Patients Receiving Pre -Operative Chemotherapy for Breast Carcinoma. Annals of
Surgical Oncology 9(3):243-247, 2002.
10. Gonzalez GM, Tijerina R, Najvar L, Ri naldi M, Yeh I, Graybill JR. Experimental murine model of disseminated pseudallescheriases . Med Mycol 40(3):243-8, 2002.
11. Yeh I, Dimitrov D, Otto P, Miller AR, Kahlenberg MS, Cruz A. Pathologic review of atypical hyperplasia identified by image-guided needle core breast biopsy: correlation with excision specimen. Arch Path & Lab Med (in press, 2002).
12. Solin LJ, McCormick,…, Yeh I, et al: An international collaborative study: A 15 year experience. In Silverstein M (ed): Ductal Carcinoma In Situ of the Breast, Second Edition. Philadelphia, Lippincott Williams and Wilkins, 2002.
13. Yeh I, Miller AR: Undesirable Cytokeratin Immunoreactivity of Native Non-Epithelial Cells in Sentinel Lymph Nodes from Patients with Breast Carcinoma. Archives of Path Lab Med. 126:248, 2002.
14. Yeh I. Measuring HER-2 in breast cancer: IHC, FISH, or ELISA? Am J Clin Pathol 117 (Suppl 1):S26-S35, 2002.
Updated on 09/10/2002
